The plastic syringe market is projected to grow from USD 3.9 billion in 2025 to USD 6.4 billion by 2035, registering a CAGR of 5% during the forecast period. Sales in 2024 reached USD 3.7 billion, reflecting growing demand driven by increasing healthcare needs and the widespread use of injectable therapies.
Increasing demand for disposable medical devices, rising prevalence of chronic diseases, and the expansion of vaccination programs globally drives the growth. The shift towards single-use syringes for enhanced safety and infection control further propels market expansion.
Plastic syringes are predominantly made from materials like polypropylene (PP), polyethylene (PE), and polycarbonate (PC), with PP being the most commonly used due to its durability and cost-effectiveness. The market is segmented into various types, including hypodermic syringes, oral syringes, and prefilled syringes.
Prefilled syringes are gaining traction owing to their convenience and reduced risk of contamination, especially in the administration of vaccines and insulin. The growing trend of self-administration of drugs at home has also increased the demand for user-friendly syringe designs.
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed an expansion and modernization project at its Lohr site with a total investment volume of around EUR 100 million after more than two years of planning and construction.
“Our investments in cutting-edge production technology, such as the new facility in Lohr, secure the future,” explains Dietmar Siemssen, CEO of Gerresheimer AG. “With state-of-the-art facilities for high-value products, we are strengthening our competitiveness, securing long-term jobs in the region and making significant progress toward our ambitious sustainability goals.”
The plastic syringe market is witnessing innovations aimed at enhancing safety and sustainability. Manufacturers are developing syringes with safety features like retractable needles to prevent needle stick injuries.
Additionally, there's a growing focus on producing syringes using recyclable materials to reduce environmental impact. The integration of smart technologies, such as dose-tracking and connectivity features, is also emerging, aiming to improve patient compliance and monitoring.
Hypodermic syringes are expected to hold a commanding 58% share of the plastic syringe market by 2025, owing to their critical role in the safe and precise administration of medications, vaccines, and diagnostic fluids. Designed for penetration through the skin and into veins or muscles, these syringes are widely used across hospitals, clinics, and home care environments.
Plastic hypodermic syringes offer advantages including sterility, affordability, disposability, and minimal risk of cross-contamination. Their adaptability to a wide range of needle gauges and volumes makes them indispensable in various medical applications, including anesthesia delivery, blood draws, and immunizations. The COVID-19 pandemic and subsequent emphasis on vaccination infrastructure have further accelerated their adoption, leading to increased investments in production capacity and inventory stockpiling.
Regulatory agencies and healthcare providers continue to promote the use of safety-engineered and auto-disable hypodermic syringes to prevent needle-stick injuries and ensure one-time usage. Additionally, advancements in material composition-such as BPA-free and latex-free plastics-enhance safety for both users and patients. With continued global efforts to expand access to basic and preventive healthcare, the demand for hypodermic plastic syringes will remain robust, particularly in immunization programs, emergency care, and chronic disease management.
Insulin syringes are projected to account for 29% of the plastic syringe market by 2025, driven by the growing global prevalence of diabetes and the widespread shift toward self-administered therapy. Designed specifically for subcutaneous injection of insulin, these syringes feature finer needles, clear dosage markings, and low dead space to ensure accurate and pain-minimized delivery for diabetic patients.
Plastic insulin syringes are typically used multiple times per day by Type 1 and insulin-dependent Type 2 diabetics, making ease of use and cost-efficiency paramount. These syringes are available in various barrel capacities-commonly 0.3 ml, 0.5 ml, and 1 ml-and are compatible with U-100 insulin concentrations, supporting safe and accurate dosing.
The rise of home-based healthcare, greater public awareness of diabetes management, and improvements in diabetic education programs are fueling demand for user-friendly injection devices. While insulin pens and pumps are gaining traction, insulin syringes remain the preferred option in many regions due to their affordability and insurance coverage.
With the diabetic population on the rise, insulin syringes will continue to play a vital role in accessible, daily disease management, especially in emerging economies where disposable plastic syringes provide a cost-effective solution for chronic care.
Increase in Health Issues
A vast population around the world suffers from chronic diseases such as diabetes, which requires insulin shots. The aging population increases the demand as older people need frequent medical care.
Healthcare is improving in developing countries, leading to more hospitals and clinics that need syringes. Vaccination programs for children and adults also create a steady need for syringes.
Safe Use of Syringes and New Treatments
Syringes need to be used only once to avoid infections, which makes the demand for them even higher. The COVID-19 pandemic showed how quickly the demand for syringes can rise when there is a need for mass vaccination.
Medicines, such as cancer drugs and biologics, need to be injected, which increases the use of syringes. More people are also giving themselves injections at home, which leads to more demand for easy-to-use syringes.
Technological Advancements in Syringe Design
New technology is improving syringe design and driving the market ahead. A major innovation is the advent of safety syringes that help prevent needle stick injuries. These syringes have features such as retractable needles or built-in safety measures, making them safer for both doctors and patients.
Also, better materials and manufacturing methods are making plastic syringes more reliable and high-quality, which is increasing their demand in healthcare.
Plastic Medical Wastes is Harmful for the Environment
The growing environmental concern over plastic medical waste is becoming a significant challenge. Hospitals and clinics discard millions of plastic syringes daily, creating mountains of non-biodegradable trash. Many countries are pushing healthcare facilities to reduce plastic waste, and some are exploring alternatives or recycling programs.
This environmental pressure could slow down market growth as healthcare providers look for more sustainable options or ways to reduce syringe usage where possible.
High Cost of Advanced Syringe Technologies
Another factor slowing down the plastic syringe market is the high cost of new technologies. Advanced syringes, such as safety syringes, prevent needle injuries, and smart syringes that track medicine delivery, can be much more expensive than regular syringes.
This higher price can make it hard for hospitals and clinics, especially in developing countries, to buy them. Many healthcare providers have tight budgets and may choose to stick with cheaper, traditional syringes instead. Because of this, the growth of the plastic syringe market can be limited by the high costs of these newer, safer options.
Safety Syringes with Retractable Needles
Safety syringes prevent accidental needle sticks, which are dangerous for healthcare workers. After using these needles, the needle automatically pulls back into the barrel of the syringe, making it impossible to reuse and safer to dispose of.
Many hospitals are switching to safety syringes, even though they cost more because they protect the healthcare personnel from injuries and potential infections. It is more trending in the developed countries that have stricter worker safety regulations.
| Countries | CAGR |
|---|---|
| USA | 4.8% |
| UK | 4.5% |
| Germany | 11.1% |
| China | 5.2% |
| India | 5.5% |
The USA accounts for 28.2% value share in the global market, and is expected to reach a CAGR of 4.8% over the forecast period. The plastic syringe market in USA is growing because of a focus on healthcare and safety.
The USA Food and Drug Administration (FDA) has set strict guidelines for medical devices, including syringes, which encourages manufacturers to develop safer and more effective products. Additionally, the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, increases the demand for injectable medications.
The trend towards home healthcare is also significant, as more patients prefer self-injection for convenience. Furthermore, the COVID-19 pandemic highlighted the importance of vaccination, leading to heightened production and distribution of syringes for mass immunization programs.
UK is expected to witness a CAGR of 4.5% during the forecast period. This growth is mainly because of efforts by the National Health Service (NHS) to ensure patient safety and better care. The NHS encourages the use of single-use syringes to avoid infections and make sure medicine is given safely.
The increasing focus on preventive healthcare and vaccination programs has also raised the demand for syringes. Also, as the population gets older, more people need medical treatments, leading to higher demand for syringes. The government's efforts to improve healthcare services are also helping the market grow.
The plastic syringe market in Germany is expected to grow at a positive CAGR during the forecast period. The growth is witnessed due to a strong healthcare system and focus on patient safety. The country has strict rules for medical devices to make sure syringes are of high quality. The rising number of chronic diseases such as diabetes and cancer is increasing the need for injectable medications.
Germany is also known for its advanced healthcare technology, which drives new designs and safety features for syringes. The focus on vaccination programs, especially during the COVID-19 pandemic, has increased the demand for syringes. Plus, the growing trend of home healthcare, where patients give themselves medicine, is driving the need for easy-to-use syringes.
China is expected to grow at a CAGR of 5.2% during the forecast period. China's plastic syringe market is growing quickly because of its large population and increasing healthcare needs. The government has invested a lot in healthcare to make medical services more accessible.
Programs like the Healthy China 2030 initiative encourage better healthcare practices, such as vaccination and managing chronic diseases, which increases the demand for syringes. The growth of private hospitals and clinics also adds to this demand as they need a constant supply of syringes for medical procedures. Also, more people are becoming aware of hygiene and safety in healthcare, leading to more use of single-use syringes.
India is expected to grow at a CAGR of 5.5% during the forecast period. In India, the plastic syringe market is growing because both chronic diseases and the population are increasing. The government has started several health programs such as the National Health Mission to improve healthcare access and quality.
This includes promoting vaccinations and maternal health, which drives the need for syringes. The growth of healthcare facilities, such as private hospitals and clinics has accelerated the need for medical supplies. Also, more people are opting for self-medication and home healthcare, where they manage their own health.
| Company Name | Expertise |
|---|---|
| Retrago | Focuses on automatic retractable syringes |
| Apiject Systems Corp. | Specializes in single-use, pre-filled plastic syringes using blow-fill-seal (BFS) technology, capable of high-volume production to efficiently address global vaccination needs. |
| Credence MedSystems | Develops syringes with built-in safety features, such as self-retracting needles, and collaborates with pharmaceutical manufacturers for integrated drug delivery systems. |
Several strategies are used by the syringe companies to grow. Their focus is on innovation by developing new types of syringes, like safety-engineered and pre-filled syringes, to meet the needs of healthcare providers and patients.
They also invest in marketing campaigns to raise awareness about the benefits of their products. Collaborating with hospitals, clinics, and pharmacies is another key strategy, as it helps companies understand customer needs and build strong relationships.
Additionally, many companies are exploring sustainable practices, such as recycling programs, to address environmental concerns and attract eco-conscious consumers. Overall, these strategies aim to improve product quality, increase sales, and enhance customer satisfaction in the syringe market.
The plastic syringe market is segmented into administration route, application, and region.
By administration route, the market is sub-segmented into hypodermic syringe, and oral syringe
By application, the market is sub-segmented into tuberculin syringe, insulin syringe, prefilled syringe, and others
By region, the market is sub-segmented into North America, Latin America, Western Europe, South Asia and Pacific, East Asia, and Middle East and Africa
The plastic syringe market was valued at USD 3.9 billion in 2025.
The market is predicted to reach a size of USD 6.4 billion by 2035.
Some of the key companies manufacturing plastic syringes include Becton, Dickinson and Company, Braun Medical Inc., Gerresheimer AG, Terumo Corporation, and others.
The U.S. is a prominent hub for plastic syringe manufacturers, which is expected to grow at a CAGR of 4.8% over the forecast period 2025 to 2035.
Explore Packaging Formats Insights
Plastic Syringe Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
